- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03432117
Evaluate Efficacy of Respiratory Rehabilitation Personalized Mobile Services for Respiratory Diseases
Multicenter Prospective Clinical Trial to Evaluate Efficacy of Respiratory Rehabilitation Personalized Mobile Services for Respiratory Diseases
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients with Lung Cancer or COPD who need respiratory rehabilitation were enrolled in this trial. The subjets were randomized to 3 group(A: Fixed respiratory rehabilitation program group, B: Mixed respiratory rehabilitation program group(Fixed respiratory rehabilitation for 6 weeks, and then responsive respiratory rehabilitation for 6 weeks) and C: Control group(Ordinary rehabilitation service of the site)).
Patients in Group A&B were provided with mobile application and wearable O2 saturation machine and mobile application monitors physical activity and provides
- how to do stretching, weight training with The-ra Band
- daily and weekly target of exercise
- alarm algorithms depending on patient's respiratory status(purse rate and O2 saturation)
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 05505
- Asan Medical Center
-
Seoul, Korea, Republic of, 07061
- SMG-SNU Boramae Medical Center
-
Seoul, Korea, Republic of, 02447
- Kyunghee University Medical Center
-
-
Gangwon-do
-
Wonju, Gangwon-do, Korea, Republic of, 26426
- Wonju Severance Christian Hospital
-
-
Gyeonggi-do
-
Guri-si, Gyeonggi-do, Korea, Republic of, 11923
- Hanyang University Guri Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with Lung cancer or COPD
Patients with FEV1<80% or FVC<80% in Pulmonary function test
- In case of COPD, post-bronchodilator FEV1 or FVC will be used.
- Exceptionally Lung Cancer patients with operation, FEV1>80% or FVC>80% will be permitted
- The distance walked for 6 minutes in 6-minute walk test ≥ 150 m
- Patients with android phone
- Patients who voluntarily agree to study participation and provide written informed consent form
Exclusion Criteria:
- Patients with diseases which could be cause of death or significant disability for 1 year after study enrollment.
- Patients with diseases that are difficult to walk or improve walking at screening
- Patients with significant diseases which are difficult to include in this study in accordance with the investigator's judgment
- Patients who are illiterate or have communication limitations
- Patients who have a difficulty to complete a questionnaire or are uncooperative due to deterioration of recognition function
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Fixed respiratory rehabilitation program(A)
respiratory rehabilitation program for 12 weeks
|
There are 6 step-exercise presented in the application and initial target of exercise will be set according to subject condition.
After subject completes targeted exercise, next step will be started.
|
Experimental: Mixed respiratory rehabilitation program(B)
Fixed respiratory rehabilitation for 6 weeks, and then responsive respiratory rehabilitation for 6 weeks
|
There are 6 step-exercise presented in the application and initial target of exercise will be set according to subject condition.
After subject completes targeted exercise, next step will be started.
The application provide responsive exercise program by changing type and numbers of exercise according to subject condition and exercise ability (This will be assessed with monitored O2 saturation, symptom of dyspnea and pulse rate during exercise)
|
No Intervention: Control(C)
Ordinary rehabilitation service of the site for 12 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change from baseline in Modified Medical Research Council dyspnea score
Time Frame: 12 weeks
|
The MMRC dyspnea scale is a five-option grading system.
The scale measures a person's limitation base on a scale of 0-4 and uses the final value to determine how much disability is caused by shortness of breath.
|
12 weeks
|
change from baseline in COPD Assessment Test(CAT) score
Time Frame: 12 weeks
|
The CAT is a validated, short and simple subject completed questionnaire which has been developed for use in routine clinical practice to measure the health status of subjects with COPD.
Subjects are scored on eight items (cough, phlegm, chest tightness, breathlessness, activity limitation, confidence, sleep and energy) on a scale of 0-5 depending on their impact.
The sum of scores for each item gives the subject's impact score ranging from 0 (no impact) to 40 (worst possible impact).
|
12 weeks
|
change from baseline in real distance walked for 6 minutes
Time Frame: 12 weeks
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change from baseline in Physical activity
Time Frame: 12 weeks
|
Physical activity will be assessed with the daily walking distance monitored by the application and wearable device.
|
12 weeks
|
subject satisfaction with health status
Time Frame: 12 weeks
|
changed from baseline in EQ-5D-5L
|
12 weeks
|
subject satisfaction with service
Time Frame: 12 weeks
|
Assessment tool: Patient's Global Assessment - Subjects are scored on four items (general, easy-to-follow, helpful in exercise and Physical fitness ) on a scale of 1-5 depending on their satisfaction level.
The sum of scores for each item will be used for assessement of the subject's satisfaction in the trial.
|
12 weeks
|
change in Healthcare resource utilisation(the number of hospitalization) in COPD(chronic obstructive pulmonary disease) Patients
Time Frame: 12 weeks
|
Comparison with the number of hospitalization during the same period last year
|
12 weeks
|
change in Healthcare resource utilisation(hospitalization period) in COPD(chronic obstructive pulmonary disease) Patients
Time Frame: 12 weeks
|
Comparison with hospitalization period during the same period last year
|
12 weeks
|
change in Healthcare resource utilisation(the number of visiting emergency room) in COPD(chronic obstructive pulmonary disease) Patients
Time Frame: 12 weeks
|
Comparison with the number of visiting emergency room during the same period last year
|
12 weeks
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Cox NS, Dal Corso S, Hansen H, McDonald CF, Hill CJ, Zanaboni P, Alison JA, O'Halloran P, Macdonald H, Holland AE. Telerehabilitation for chronic respiratory disease. Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013040. doi: 10.1002/14651858.CD013040.pub2.
- Kwon H, Lee S, Jung EJ, Kim S, Lee JK, Kim DK, Kim TH, Lee SH, Lee MK, Song S, Shin K. An mHealth Management Platform for Patients with Chronic Obstructive Pulmonary Disease (efil breath): Randomized Controlled Trial. JMIR Mhealth Uhealth. 2018 Aug 24;6(8):e10502. doi: 10.2196/10502.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- C2016-00568
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Cancer
-
M.D. Anderson Cancer CenterRecruitingStage III Lung Cancer AJCC v8 | Lung Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage... and other conditionsUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingStage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingCaregiver | Stage III Lung Cancer AJCC v7 | Stage I Lung Cancer AJCC v7 | Stage II Lung Cancer AJCC v7 | Stage IB Lung Cancer AJCC v7 | Stage IA Lung Cancer AJCC v7 | Stage IIA Lung Cancer AJCC v7 | Stage IIB Lung Cancer AJCC v7 | Stage IIIA Lung Cancer AJCC v7 | Stage IIIB Lung Cancer AJCC v7United States
-
Dana-Farber Cancer InstituteMedWaves, IncNot yet recruitingLung Cancer | Lung Cancer Stage I | Lung Cancer Stage II | Stage I Lung Cancer | Stage I - II Primary Lung Cancer | Stage II Lung CancerUnited States
-
WindMIL TherapeuticsBristol-Myers SquibbTerminatedNSCLC | Lung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer MetastaticUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Genentech, Inc.RecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung... and other conditionsUnited States
-
Emory UniversityNational Cancer Institute (NCI)TerminatedLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
University of California, San FranciscoMerck Sharp & Dohme LLCWithdrawnLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Metastatic Lung Carcinoma | Stage IV Lung Cancer AJCC v8 | Head and Neck Carcinoma | Lung Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung... and other conditionsUnited States
Clinical Trials on Fixed respiratory rehabilitation
-
University of Roma La SapienzaCompletedEdentulous Patients
-
University Hospital, LilleMinistry of Health, FranceUnknownChronic Obstructive Pulmonary DiseaseFrance
-
Chest Hospital, Ministry of Health and Welfare,...CompletedChronic Obstructive Pulmonary Disease (COPD)Taiwan
-
Cardenal Herrera UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...Spanish Clinical Research Network - SCReN; Spanish Society of Pneumology and...CompletedPulmonary Disease, Chronic ObstructiveSpain
-
Bezmialem Vakif UniversityCompletedHemiplegia | Respiratory AbnormalityTurkey
-
University of MaltaCompletedInterstitial Lung DiseaseMalta
-
Centre Hospitalier Intercommunal de Toulon La Seyne...Completed
-
University of MaltaNot yet recruitingChronic Obstructive Pulmonary Disease
-
Hospitales Universitarios Virgen del RocíoFondo de Investigacion SanitariaCompletedEmphysema | Obstructive Chronic Pulmonary DiseaseSpain